Open Access

[Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo

  • Authors:
    • Jia Liu
    • Bing-Fei Dong
    • Pei-Song Wang
    • Pei-You Ren
    • Shuai Xue
    • Xiao-Nan Zhang
    • Zhe Han
    • Guang Chen
  • View Affiliations

  • Published online on: March 1, 2022     https://doi.org/10.3892/or.2022.8297
  • Article Number: 86
  • Copyright : © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

May-2022
Volume 47 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu J, Dong B, Wang P, Ren P, Xue S, Zhang X, Han Z and Chen G: [Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma <em>in vitro</em> and <em>in vivo</em>. Oncol Rep 47: 86, 2022
APA
Liu, J., Dong, B., Wang, P., Ren, P., Xue, S., Zhang, X. ... Chen, G. (2022). [Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma <em>in vitro</em> and <em>in vivo</em>. Oncology Reports, 47, 86. https://doi.org/10.3892/or.2022.8297
MLA
Liu, J., Dong, B., Wang, P., Ren, P., Xue, S., Zhang, X., Han, Z., Chen, G."[Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma <em>in vitro</em> and <em>in vivo</em>". Oncology Reports 47.5 (2022): 86.
Chicago
Liu, J., Dong, B., Wang, P., Ren, P., Xue, S., Zhang, X., Han, Z., Chen, G."[Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma <em>in vitro</em> and <em>in vivo</em>". Oncology Reports 47, no. 5 (2022): 86. https://doi.org/10.3892/or.2022.8297